413 related articles for article (PubMed ID: 32703312)
1. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
[TBL] [Abstract][Full Text] [Related]
2. Pancreatitis and PDAC: association and differentiation.
Elsherif SB; Virarkar M; Javadi S; Ibarra-Rovira JJ; Tamm EP; Bhosale PR
Abdom Radiol (NY); 2020 May; 45(5):1324-1337. PubMed ID: 31705251
[TBL] [Abstract][Full Text] [Related]
3. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
Jia H; Li J; Huang W; Lin G
BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
[TBL] [Abstract][Full Text] [Related]
4. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies.
Kim B; Lee SS; Sung YS; Cheong H; Byun JH; Kim HJ; Kim JH
J Magn Reson Imaging; 2017 Jan; 45(1):260-269. PubMed ID: 27273754
[TBL] [Abstract][Full Text] [Related]
5. Chronic Pancreatitis or Pancreatic Tumor? A Problem-solving Approach.
Wolske KM; Ponnatapura J; Kolokythas O; Burke LMB; Tappouni R; Lalwani N
Radiographics; 2019; 39(7):1965-1982. PubMed ID: 31584860
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory mimickers of pancreatic adenocarcinoma.
Kothari K; Lopes Vendrami C; Kelahan LC; Shin JS; Mittal P; Miller FH
Abdom Radiol (NY); 2020 May; 45(5):1387-1396. PubMed ID: 31559473
[TBL] [Abstract][Full Text] [Related]
7. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
Ha J; Choi SH; Kim KW; Kim JH; Kim HJ
Dig Liver Dis; 2022 Jul; 54(7):849-856. PubMed ID: 34903501
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
9. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
[TBL] [Abstract][Full Text] [Related]
11. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis.
Zhang H; Meng Y; Li Q; Yu J; Liu F; Fang X; Li J; Feng X; Zhou J; Zhu M; Li N; Lu J; Shao C; Bian Y
Eur Radiol; 2022 Sep; 32(9):6336-6347. PubMed ID: 35394185
[TBL] [Abstract][Full Text] [Related]
12. Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas: monoexponential and biexponential apparent diffusion parameters and histopathological correlations.
Ma C; Li Y; Wang L; Wang Y; Zhang Y; Wang H; Chen S; Lu J
Cancer Imaging; 2017 Apr; 17(1):12. PubMed ID: 28454564
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Cancer and Its Mimics.
Miller FH; Lopes Vendrami C; Hammond NA; Mittal PK; Nikolaidis P; Jawahar A
Radiographics; 2023 Nov; 43(11):e230054. PubMed ID: 37824413
[TBL] [Abstract][Full Text] [Related]
14. Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma.
Gong XH; Xu JR; Qian LJ
Abdom Radiol (NY); 2021 Sep; 46(9):4226-4237. PubMed ID: 33914139
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
[TBL] [Abstract][Full Text] [Related]
16. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
[TBL] [Abstract][Full Text] [Related]
17. The role of EUS in relation to other imaging modalities in the differential diagnosis between mass forming chronic pancreatitis, autoimmune pancreatitis and ductal pancreatic adenocarcinoma.
Iglesias-García J; Lindkvist B; Lariño-Noia J; Domínguez-Muñoz JE
Rev Esp Enferm Dig; 2012 Jun; 104(6):315-21. PubMed ID: 22738702
[TBL] [Abstract][Full Text] [Related]
18. Intravoxel incoherent motion magnetic resonance imaging for differentiating metastatic and non-metastatic lymph nodes in pancreatic ductal adenocarcinoma.
Rong D; Mao Y; Hu W; Xu S; Wang J; He H; Li S; Zhang R
Eur Radiol; 2018 Jul; 28(7):2781-2789. PubMed ID: 29404768
[TBL] [Abstract][Full Text] [Related]
19. Large Duct Pancreatic Ductal Adenocarcinoma: A Morphological Variant of Pancreatic Ductal Adenocarcinoma With Distinct CT and MRI Characteristics.
Choi SJ; Kim SJ; Kim DW; Lee SS; Hong SM; Kim KW; Kim JH; Kim HJ; Byun JH
Korean J Radiol; 2023 Dec; 24(12):1232-1240. PubMed ID: 38016682
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
